Global Inflammatory Bowel Disease Therapeutics Market Research Report 2023

Publisher Name :
Date: 31-Jan-2023
No. of pages: 81
Inquire Before Buying

Highlights

The global Inflammatory Bowel Disease Therapeutics market was valued at US$ 17970 million in 2022 and is anticipated to reach US$ 22210 million by 2029, witnessing a CAGR of 3.6% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Inflammatory Bowel Disease Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Inflammatory Bowel Disease Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Inflammatory Bowel Disease Therapeutics in Hospital Use is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Inflammatory Bowel Disease Therapeutics include Abbvie, Johnson & Johnson, GlaxoSmithKline, Merck and Novartis, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inflammatory Bowel Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inflammatory Bowel Disease Therapeutics.

The Inflammatory Bowel Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Inflammatory Bowel Disease Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inflammatory Bowel Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Abbvie

- Johnson & Johnson

- GlaxoSmithKline

- Merck

- Novartis

Segment by Type

- Anti-inflammatory Biologics

- Non-Steroidal Anti-inflammatory drugs (NSAIDs)

- Corticosteroids

Segment by Application

- Hospital Use

- Home Use

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inflammatory Bowel Disease Therapeutics companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Inflammatory Bowel Disease Therapeutics Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
1.2.4 Corticosteroids
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Use
1.3.3 Home Use
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease Therapeutics Market Perspective (2018-2029)
2.2 Inflammatory Bowel Disease Therapeutics Growth Trends by Region
2.2.1 Global Inflammatory Bowel Disease Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Inflammatory Bowel Disease Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Inflammatory Bowel Disease Therapeutics Market Dynamics
2.3.1 Inflammatory Bowel Disease Therapeutics Industry Trends
2.3.2 Inflammatory Bowel Disease Therapeutics Market Drivers
2.3.3 Inflammatory Bowel Disease Therapeutics Market Challenges
2.3.4 Inflammatory Bowel Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease Therapeutics Players by Revenue
3.1.1 Global Top Inflammatory Bowel Disease Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Inflammatory Bowel Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inflammatory Bowel Disease Therapeutics Revenue
3.4 Global Inflammatory Bowel Disease Therapeutics Market Concentration Ratio
3.4.1 Global Inflammatory Bowel Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Therapeutics Revenue in 2022
3.5 Inflammatory Bowel Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Inflammatory Bowel Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Inflammatory Bowel Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Bowel Disease Therapeutics Breakdown Data by Type
4.1 Global Inflammatory Bowel Disease Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Type (2024-2029)
5 Inflammatory Bowel Disease Therapeutics Breakdown Data by Application
5.1 Global Inflammatory Bowel Disease Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Inflammatory Bowel Disease Therapeutics Market Size (2018-2029)
6.2 North America Inflammatory Bowel Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2018-2023)
6.4 North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inflammatory Bowel Disease Therapeutics Market Size (2018-2029)
7.2 Europe Inflammatory Bowel Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2018-2023)
7.4 Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inflammatory Bowel Disease Therapeutics Market Size (2018-2029)
9.2 Latin America Inflammatory Bowel Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Detail
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Inflammatory Bowel Disease Therapeutics Introduction
11.1.4 Abbvie Revenue in Inflammatory Bowel Disease Therapeutics Business (2018-2023)
11.1.5 Abbvie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapeutics Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Inflammatory Bowel Disease Therapeutics Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Inflammatory Bowel Disease Therapeutics Introduction
11.4.4 Merck Revenue in Inflammatory Bowel Disease Therapeutics Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Inflammatory Bowel Disease Therapeutics Introduction
11.5.4 Novartis Revenue in Inflammatory Bowel Disease Therapeutics Business (2018-2023)
11.5.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Anti-inflammatory Biologics
Table 3. Key Players of Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Table 4. Key Players of Corticosteroids
Table 5. Global Inflammatory Bowel Disease Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Inflammatory Bowel Disease Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Inflammatory Bowel Disease Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Inflammatory Bowel Disease Therapeutics Market Share by Region (2018-2023)
Table 9. Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Inflammatory Bowel Disease Therapeutics Market Share by Region (2024-2029)
Table 11. Inflammatory Bowel Disease Therapeutics Market Trends
Table 12. Inflammatory Bowel Disease Therapeutics Market Drivers
Table 13. Inflammatory Bowel Disease Therapeutics Market Challenges
Table 14. Inflammatory Bowel Disease Therapeutics Market Restraints
Table 15. Global Inflammatory Bowel Disease Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Inflammatory Bowel Disease Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top Inflammatory Bowel Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Therapeutics as of 2022)
Table 18. Ranking of Global Top Inflammatory Bowel Disease Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Inflammatory Bowel Disease Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Inflammatory Bowel Disease Therapeutics Product Solution and Service
Table 22. Date of Enter into Inflammatory Bowel Disease Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Inflammatory Bowel Disease Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Type (2024-2029)
Table 28. Global Inflammatory Bowel Disease Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Application (2018-2023)
Table 30. Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Application (2024-2029)
Table 32. North America Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 47. Abbvie Company Detail
Table 48. Abbvie Business Overview
Table 49. Abbvie Inflammatory Bowel Disease Therapeutics Product
Table 50. Abbvie Revenue in Inflammatory Bowel Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 51. Abbvie Recent Development
Table 52. Johnson & Johnson Company Detail
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Inflammatory Bowel Disease Therapeutics Product
Table 55. Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 56. Johnson & Johnson Recent Development
Table 57. GlaxoSmithKline Company Detail
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Product
Table 60. GlaxoSmithKline Revenue in Inflammatory Bowel Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 61. GlaxoSmithKline Recent Development
Table 62. Merck Company Detail
Table 63. Merck Business Overview
Table 64. Merck Inflammatory Bowel Disease Therapeutics Product
Table 65. Merck Revenue in Inflammatory Bowel Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Inflammatory Bowel Disease Therapeutics Product
Table 70. Novartis Revenue in Inflammatory Bowel Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inflammatory Bowel Disease Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Inflammatory Bowel Disease Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Anti-inflammatory Biologics Features
Figure 4. Non-Steroidal Anti-inflammatory drugs (NSAIDs) Features
Figure 5. Corticosteroids Features
Figure 6. Global Inflammatory Bowel Disease Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Inflammatory Bowel Disease Therapeutics Market Share by Application: 2022 VS 2029
Figure 8. Hospital Use Case Studies
Figure 9. Home Use Case Studies
Figure 10. Inflammatory Bowel Disease Therapeutics Report Years Considered
Figure 11. Global Inflammatory Bowel Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Inflammatory Bowel Disease Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Inflammatory Bowel Disease Therapeutics Market Share by Region: 2022 VS 2029
Figure 14. Global Inflammatory Bowel Disease Therapeutics Market Share by Players in 2022
Figure 15. Global Top Inflammatory Bowel Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Therapeutics Revenue in 2022
Figure 17. North America Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Inflammatory Bowel Disease Therapeutics Market Share by Country (2018-2029)
Figure 19. United States Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Inflammatory Bowel Disease Therapeutics Market Share by Country (2018-2029)
Figure 23. Germany Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Share by Region (2018-2029)
Figure 31. China Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Inflammatory Bowel Disease Therapeutics Market Share by Country (2018-2029)
Figure 39. Mexico Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Share by Country (2018-2029)
Figure 43. Turkey Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Abbvie Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2018-2023)
Figure 46. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2018-2023)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2018-2023)
Figure 48. Merck Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2018-2023)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
  • Global Ultrasonic Scalpel Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 01-Jun-2023        Price: US 3260 Onwards        Pages: 116
    The Ultrasonic Scalpel market revenue was 2392.96 Million USD in 2022, and will reach 3682.71 Million USD in 2028, with a CAGR of 7.45% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Ultrasonic Scalpel industry, and breaks down according to the type, application, and consumption area of Ultrasonic Scalpel. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and......
  • Global Medical Headlamp Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 01-Jun-2023        Price: US 3260 Onwards        Pages: 130
    The Medical Headlamp market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Medical Headlamp industry, and breaks down according to the type, application, and consumption area of Medical Headlamp. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the lea......
  • Global Non-Invasive Prenatal Testing Devices Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 01-Jun-2023        Price: US 3260 Onwards        Pages: 108
    Prenatal screening focuses on finding problems among a large population with affordable and noninvasive methods. Non-invasive techniques include examinations of the woman's womb through ultrasonography and maternal serum screens (i.e. Alpha-fetoprotein). Blood tests for select trisomies (Down syndrome in the United States, Down and Edwards syndromes in China) based on detecting cell-free placental DNA present in maternal blood, also known as non-invasive prenatal testing (NIPT), have become avai......
  • Global Oxygen Therapy Devices Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 01-Jun-2023        Price: US 3260 Onwards        Pages: 123
    The Oxygen Therapy Devices market revenue was 2309.68 Million USD in 2022, and will reach 3198.57 Million USD in 2028, with a CAGR of 5.58% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Oxygen Therapy Devices industry, and breaks down according to the type, application, and consumption area of Oxygen Therapy Devices. The report also introduces players in the industry from the perspective of the industry chain and marketi......
  • Global Embolization Coil Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 01-Jun-2023        Price: US 3260 Onwards        Pages: 127
    The Embolization Coil market revenue was 1006.2 Million USD in 2022, and will reach 1328.85 Million USD in 2028, with a CAGR of 4.74% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Embolization Coil industry, and breaks down according to the type, application, and consumption area of Embolization Coil. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and des......
  • Global Syringe Filters Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 01-Jun-2023        Price: US 3260 Onwards        Pages: 112
    The Syringe Filters market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Syringe Filters industry, and breaks down according to the type, application, and consumption area of Syringe Filters. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leadin......
  • Global Jaundice Meter Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 01-Jun-2023        Price: US 3260 Onwards        Pages: 106
    A Jaundice meter is an instrument that measure the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are broadly utilized in children's hospitals, baby caring centers all around the world. The Jaundice Meter market revenue was 90.1 Million USD in 2022, and will reach 109.6 Million USD in 2028, with a CAGR of 3.32% during 2022-2028. This report elaborates the market size, market chara......
  • Global New Baby Monitoring System Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 01-Jun-2023        Price: US 3260 Onwards        Pages: 119
    The New Baby Monitoring System market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the New Baby Monitoring System industry, and breaks down according to the type, application, and consumption area of New Baby Monitoring System. The report also introduces players in the industry from the perspective of the industry chain and marketi......
  • Global Portable Vascular Doppler Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 01-Jun-2023        Price: US 3260 Onwards        Pages: 111
    The Portable Vascular Doppler market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Portable Vascular Doppler industry, and breaks down according to the type, application, and consumption area of Portable Vascular Doppler. The report also introduces players in the industry from the perspective of the industry chain and marketing ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs